r ITUITARY adenylate cyclase-activating polypeptide PACAP) is a neuropeptide structurally related to the peptide family consisting of glucagon, secretin, vasoactive intestinal peptide, and others (1). Two isoforms of I'ACAI', l'ACAP-27 and PACAP-38, which share the same 27 N-terminal amino acids, are derived by tissue-specific posttranslational processing of a 176-amino acid precursor (2). In the endocrine pancreas, PACAP is produced and secreted from nerve endings that innervate the islets of Langerhans (3), and PACAP is an extremely potent stimulator of glucose-dependent insulin secretion (4). Multiple isoforms of the PACAP receptor (PACAP-R) have been isolated and sequenced, including, in insulin-secreting @cells, the type 3 PACAP-R PACAP-R3), which is homologous to the rat vasoactive intestinal peptide receptor (5, 6). The type 1 PACAP-R has been shown to stimulate both CAMP accumulation (ECso 3 nM) and [3H]inositol phosphate production (ECso, 20 n& in the gonadotrope-derived c~T3-1 cell line (7). Similarly, when expressed in Xenopus oocytes, PACAP-R3 can couple to phospholipase-C as well as to adenylyl cyclase (51, but such dual coupling of I'ACAI' receptors has yet to be demonstrated in insulinoma cells or pancreatic p-cells. However, the observation that nitrendipine blocks PACAP-induced elevation of intracellular calcium ion ([Ca'+]J and insulin secretion (4) suggests that mobilization of intracellular Ca'+ stores through activation of phospholipase-C is not the primary signaling pathway of PACAP in p-cells and that stimulation of CAMP production may play a more dominant role.
In perfused rat pancreas, the two isoforms of PACAP, I'ACAP-27 and PACAP-38, induce insulin secretion in a glucose-dependent manner. PACAPis more potent than l'ACAP-27 at 5.5 rnM extracellular glucose, but the two forms are equally potent at 8.3 rnM glucose (81. In rat p-cells, both PACAPand I'ACAP-38 potentiate glucose-dependent insulin secretion at concentrations as low as 10P14-10P13 M (4). These actions of PACAP are reported to be mediated through an increase in the activity of L-type voltage-dependent calcium channels (VDCCs), because nitrendipine, a specific blocker of L-type channels, abolishes the stimulatory effects of I'ACAI? on both [Ca*+li and insulin secretion. However, the effects of PACAP on membrane currents or membrane potential were not examined (4).
As PACAP stimulates CAMP production, it is of interest to determine what effect it might exert on ion channels that are known to be regulated by this cyclic nucleotide, either through direct effects of CAMP on channel gating or via effects mediated by CAMP-dependent protein phosphorylation. Recent studies suggest that CAMP (and Ca'+) activate a nonspecific cation channel (Ca-NS channels) in the rat insulinoma cell line, CRI-Gl(9). The activation of this current in isolated inside-out membrane patches does not appear to be mediated by protein kinase-A (I'KA) and requires non-physiological cytoplasmic lCa'+l f>O.l rnM) (9, 10) (the [Caz+li required in the intact cell may be much lower). The activation of this current in viva would be expected to cause membrane depolarization and a rise in ]Caz+li, thereby triggering insulin secretion.
Glucagon-like peptide-l (GLP-1) is a potent incretin hormone produced in and released from entero-endocrine cells in the small intestine in response to the ingestion of nutrients. The stimulation of insulin secretion by GLP-1 appears to be mediated by increases in CAMP levels, which potentiate glucose-induced closure of AT&sensitive K-channels (ATP-K channels) (11). This closure leads to membrane depolarization and activation of VDCCs, resulting in a rise of [Caz+li, which triggers insulin secretion. GLP-1 is a member of the group of peptides related in structure to PACAP, and the glucose-dependent insulinotropic actions of PACAP might be expected to result from a similar mechanism of action. In addition to these effects, CAMP has been reported to enhance the current through L-type Ca*+ channels, by slowing their inactivation, and to have direct stimulatory effects on exocytosis (121.
The aim of the present study was to examine further the signal transduction pathway of PACAP in HIT-T15 cells using fura-fluorescence ratio measurements of [Ca*+li combined with perforated patch recording (13) of the membrane potential or membrane current. We show that PACAP induces depolarization of HIT-T15 cells by reducing the membrane conductance, raising the excitability of cells, and voltage-independent activation of an inward current that is predominantly carried by Na+. Depolarization of the cell will activate VDCCs and reduce a rise in [Ca'+]i. However, Y+ PACAP also raises [Ca Ii in cells held under voltage clamp, negative to the threshold for activation of VDCCs, by mobilization of intracellular stores and activation of a Ca*+ release-activated Ca*+-current fIc&.
As I'ACAI' is reported to be the most potent insulinotropic peptide known (4), we propose that PACAP may play an important role in a neuro-entero-endocrine loop to potentiate insulin secretion during the fasting to feeding transition, before intestinal incretins, such as GLP-1, have an effect. 
Results
Both PACAP- (Fig. 1, A and B) and PACAP- (Fig. 1C ) induced rises in [Ca2+li of HIT-T15 cells preequilibrated in a fixed concentration (2 rnM) of glucose, consistent with the presence of PACAP-R3 receptors in these cells (51. Responses to PACAP were of variable duration and were either transient (Fig. 1A) or prolonged (Fig. 1, B and C) . Similar responses were seen after application of forskolin (100 PM), 8Br-CAMP (1 rnM1, or Sp-CAMPS (100 FM; Fig. lD1 . By analogy with the effects of the related peptide, GLP-1, on rat P-cells (ll), PACAP might be expected to increase [Ca2+li by potentiating the glucose-dependent closure of ATP-K channels, resulting in membrane depolarization and opening of VDCCs. The membrane conductance of a HIT-T15 cell was monitored in perforated patch voltage clamp by holding the cell at -80 mV and applying l-set steps of 220 mV. In this experiment, 10 nM PACAPproduced about a 50% decrease in membrane conductance, with only a small effect on the holding current (IJ. This observation suggests that glucose-dependent inhibition of the ATP-sensitive K current by PACAP contributes to its ability to generate membrane depolarization (see below) and a consequent rise in [Ca2+li, as previously shown for GLP-1 (111.
Simultaneous recordings of membrane potential and [Caz+Ji in current-clamped HIT-T15 cells show that PACAPcauses membrane depolarization, the triggering of action potentials, and a simultaneous rise in [Caz+li (Fig.  3 , A and BI. However, the same cell held under voltage clamp 'at -70 mV, negative to the threshold for activation of VDCCs (17), responded to a second application of PACAPwith a pronounced inward current (Fig. 3C ) and a much larger and more prolonged rise in [Ca*+]i (Fig. 3D ). This type of response was observed more fre 2 uently than that illustrated in Fig. 2 . The larger rise in [Ca +]i observed under voltage clamp, compared to current clamp, in this cell might be explained by the increased electrical driving force for cation entry through open channels, because under voltage clamp recording conditions, the membrane potential was held at -70 mV, whereas under current clamp recording conditions, the membrane potential shifts to about -20 mV.
Removal of extracellular Ca*+ fCa'+J during the response to PACAP reversibly abolished the rise in [Ca2+li (Fig. 4A) Interestingly, PACAP produced no rise in ]CazWli in the presence of Ca*+O, but in the absence of Nat0 (Fig. 4B) . A similar dependence on Na+O has also been demonstrated for the PACAP-related peptide, GLP-1, in rat islets (18). The Na+O dependence of the rise in ]Caz+li in response to PACAP is likely to be explained at least in part by the inhibition of the inward current, which has a large Na+ component (see below, Fig. 6A ). La3+ is frequently used as a blocker of a wide range of voltage-dependent and -independent Ca'+ channels. If the effect of PACAP on [Caz+li results from activation of such channels, then La3+ might be expected to inhibit the PACAPinduced inward current. To test this possibility, HIT-T15 cells were held under voltage clamp at -70 mV, and 2 10 mV voltage steps were applied to monitor membrane conductance. An inward current, increase in membrane conductance (Fig. 5A) , and rise in [Ca*+]i (Fig. 5B) were observed in response to PACAP-27. Direct application of 100 pM La3+ from a puffer pipette caused a reversible decrease in both the inward current and membrane conductance (Fig. 5A) , indicating that at least one component of the current is blocked by La3+. The I'ACAP-27-activated current was not completely blocked by La3+, which did, however, completely block the rise in [Ca*+]i in response to a voltage step from -70 to 0 mV (data not shown), indicating that VDCCs were fully blocked.
The current activated by PACAP is also activated by forskolin, 8Br-CAMP, and Sp-CAMPS. To obtain an estimate for the reversal potential of the current, cells were dialyzed with Cs+ (substituted for K+ in the pipette solution) in the perforated patch configuration. Voltage ramps of lOO-msec duration from -70 to 30 mV were applied, and the currents in response to these ramps before stimulation with 8Br-CAMP were subtracted from currents during the response to stimulation with 8Br-CAMP to obtain the current-voltage relation of the evoked current. These currents had an apparent reversal potential of -28.0 2 2.3 mV fn = 4). This value for the FIG. 3. Simultaneous records of [CaJ and membrane potential or membrane current. Records from a single HIT cell bathed in 2 mM glucose. Initially, the fura-2-loaded cell was nnder perforated patch current clamp and responded to the application of 10 nM PACAP-(P27) by depolarizing and tiring action potentials (A), accompanied by a rise in [Caz+li (B) . When the same cell was voltage clamped at -70 mV, application of PACAPinduced a large inward current (C) and a rise in lCa2+li CD). reversal potential is consistent with the activation of nonspecific cation channels.
In the presence of physiological ion gradients, the main charge carrier through such nonspecific cation channels would be expected to be Na +. A HIT-T15 cell stimulated with 1 rnM BBr-CAMP developed a large inward current and an increase in membrane conductance (Fig. 6A) . During the response, an extracellular solution in which Na+ had been substituted by NMG was applied, which substantially and reversibly reduced the current and membrane conductance (Fig. 6A) . The current evoked by BBr-cAMI' could also be inhibited by La3+ (Fig. 6B ).
PACAP produced a marked increase in the Mn2+ permeability of HIT cells (Fig. 7) . A 60-set pulse of Mn2+ (Mn'+ was substituted for Ca2+ of normal bath solution) applied to a single cell from a puffer pipette had no effect on the 350/380 nm fluorescence ratio (Fig. 7A ) or raw fluorescence intensity (Fig. 7B) before stimulation of the cell with PACAP-38. Stimulation with PACAP induced a rise in [Ca2+li (increased fluorescence ratio), and the subsequent application of a 60-set pulse of Mn2+ led to quenching of the fura-fluorescence (Fig. 7B) In this report we demonstrate that in HIT-T15 cells, the biologically active isoforms of I'ACAI' induce membrane depolarization through at least two distinct mechanisms. First, I'ACAI' reduces the membrane conductance and increases membrane excitability in a manner similar to that previously described for GLP-1 (11). This effect most likely results from a potentiation by I'ACAI? of the inhibitory effect of glucose on ATP-K channels. Secondly, PACAP increases membrane conductance and activates a pronounced inward current that is predominantly a Na+ current, blockable by La3+, and exhibits a reversal potential of about -28 mV. We
propose that the inward current results from activation of ion channels similar to the CAMP-and Ca2+-gated nonspecific cation channels (Ca-NS channels) reported in CRI-Gl insulinoma cells (9). I'ACAI' also induced a rise in [Ca'+]i by several distinct mechanisms. One process results from the effects on ATP-K and Ca-NS channels, as described above, leading to membrane depolarization and activation of L-type VDCCs. The Ca2+ current through VDCCs may also be enhanced by CAMP-dependent protein phosphorylation (12). A second mechanism by which PACAP raised [Ca2+li was observed under conditions in which HIT-T15 cells were voltage clamped at -70 mV (and also -120 mV; data not shown), thereby preventing the opening of VDCCs (17). Although the threshold for activation of VDCCs can shift to more negative membrane potentials under conditions of pharmacological saline and initially showed no rise in [Ca2+]i in response to a lo-set pulse of 2 nM PACAP 38 (P38) in Na-free NMG saline. In the continued presence of Na-free bathing saline, the same cell showed a large rise in [Ca2+li in response to a 10~set pulse of 2 nM PACAP 38 in sodium-containing (138 mM Na+) saline. All solutions contained 0.8 mM glucose. Similar effects were seen in all five cells tested using the same protocol. stimulation (21), these shifts would not be expected to be large enough to significantly activate VDCCs at -70 mV. Therefore, the ability of PACAP to raise [Ca'+]i under conditions of voltage clamp indicates the existence of a Ca*+ signaling mechanism involving voltage-independent Ca*+ channels and/or the release of Ca*+ from intracellular stores. These observations contrast with a previous report su gesting that the mechanism by which PACAP raises ICa F+ Ii in p-cells is by increasing the activity of L-type VDCCs (4).
We observed that PACAP was without effect on [Caz+li under conditions in which the extracellular solution contained Ca*+, but not Na+. This suggests that mobilization of intracellular Ca*+ by PACAP might be initiated by the entry of Na+ throu h Ca-NS channels and/or effects of CAMP on q+ organellar Ca stores. The elevation of [Na+li in p-cells is known to trigger Ca*+ release from intracellular stores (22). . clamp at -70 mV, and ? 10 mV steps were applied to monitor membrane conductance. Application of 10 nM PACAPto the cell induced an inward current and increased the membrane conductance, both of which were reduced by La '+ (A). The inward current was accompanied by a rise in [Ca2+li (B). [Ca2+li started to recover toward normal levels after the application of La '+ despite incomplete block of the PACAP-induced current and conductance increase.
It has also been demonstrated that the secretory granules form a storage site for intracellular Ca*+, and that this Ca*+ pool is rapidly altered by stimulation with glucose and by intracellular factors, notably CAMP and Na+i (23). Furthermore, CAMP reportedly stimulates 45Ca2+ efflux from /%cell secretory granules (24). Therefore, ample precedent exists supporting the concept of an important influence of Na+ and CAMP on p-cell Ca*+ signaling systems unrelated to VDCCs. Although the mechanism by which CAMP mobilizes Ca*+ in p-cells remains to be determined, CAMP-dependent phosphorylation of the inositol trisphosphate (II'J receptor by PKA can increase Ca*+ release (25, 26) . However, there is at present no direct evidence that the type 3 IPs receptor, located in the membrane of insulin secretory granules (27), is a substrate for PKA (28). We also report that stimulation of HIT-T15 cells by PACAP results in the activation of a Mn*+-permeant divalent cation influx pathway. This was demonstrated by the quenching of intracellular fura-fluorescence by externally applied Mn*+. Quenching is unlikely to reflect entry of Mn*+ via VDCCs, as it is well established that Mn*+ is a broad spectrum blocker of this class of Ca*+ channels. Instead, we propose that the entry of Mn*+ reflects the activation of a Ca*+-release-activated Ca*+-current (I on& (14,19 stores, because the depletion of such stores is known in some cell types to activate Ics*c. The I'ACAP-R3, present in HIT cells, couples to phospholipase-C, generation of IPa, and activation of protein kinase-C (PKC) when expressed in oocytes (5). Although such coupling has yet to be demonstrated for the native receptor in p-cells or insulinoma cells, it remains possible that an effect of PACAP on II's production or PKC activity contributes to the observed rise in [Caz+li reported here. Activation of Ic=c in RINm5F cells has been observed after stimulation of I'KC (19), and PKC can also phosphorylate Il'a receptors (291. Hence, regulation of intracellular Ca*+ stores and activation of &AC may represent an important point of convergence, at which signal transduction cross-talk occurs between the CAMP and I'LC/I'KC/Il's signaling systems in p-cells. The physiological role of PACAI' remains to be fully clarified. PACAP immunoreactivity has been observed in nerve endings within the pancreas and was occasionally found within the islets (3). These observations suggest that PACAP may have local paracrine effects in km. We propose that a neuro-entero-endocrine loop may exist whereby feeding stimulates the local release of PACAP within pancreatic islets, thereby triggering insulin secretion. This release would provide a rapid augmentation of insulin secretion before the intestinal incretins come into play.
In summary, both isopeptides of I'ACAP cause the voltage-independent activation of an inward current, which we suggest is carried through Ca-NS channels. PACAP also decreases the resting membrane conductance, probably through inhibition of ATP-K channels. These effects result in depolarization of the cell and activation of L-type VDCCs. Furthermore, there are additional mechanisms by which [Caz+li rises in a membrane potential-independent manner. Ca'+ entry through voltage-independent Ca'+ channels, including IcU,-, may contribute to the rise in [Ca*+li, and the elevation of intracellular CAMP and/or Na+ levels may stimulate Ca2+ release from intracellular stores. Acting in concert, these various Ca2+ signaling pathways are expected to exert important stimulatory influences on pancreatic insulin secretion. 
